Search Results - "HONG, Ki W"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Vascular NADH Oxidase Is Involved in Impaired Endothelium-Dependent Vasodilation in OLETF Rats, a Model of Type 2 Diabetes by KIM, Yong K, LEE, Mi-S, SON, Seok M, KIM, In J, LEE, Won S, RHIM, Byung Y, HONG, Ki W, KIM, Chi D

    Published in Diabetes (New York, N.Y.) (01-02-2002)
    “…Vascular NADH Oxidase Is Involved in Impaired Endothelium-Dependent Vasodilation in OLETF Rats, a Model of Type 2 Diabetes Yong K. Kim , Mi-S. Lee , Seok M…”
    Get full text
    Journal Article
  2. 2

    Enhanced vascular production of superoxide in OLETF rat after the onset of hyperglycemia by Kim, In J, Kim, Yong K, Son, Seok M, Hong, Ki W, Kim, Chi D

    Published in Diabetes research and clinical practice (01-04-2003)
    “…This study was aimed to characterize the vascular production of superoxide in Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a model of type 2 diabetes. The…”
    Get full text
    Journal Article
  3. 3

    4-hydroxynonenal contributes to macrophage foam cell formation through increased expression of class A scavenger receptor at the level of translation by Yun, Mi R., Im, Dong S., Lee, Seung J., Woo, Joong W., Hong, Ki W., Bae, Sun S., Kim, Chi D.

    Published in Free radical biology & medicine (15-07-2008)
    “…4-Hydroxynonenal (HNE) is known to be atherogenic, but its mechanism of action in atherogenesis is not clear. Therefore, this study investigated the role of…”
    Get full text
    Journal Article
  4. 4

    Retinoid chemoprevention of aerodigestive cancer: from basic research to the clinic by Ki Hong, W, Lippman, S M, Hittelman, W N, Lotan, R

    Published in Clinical cancer research (01-07-1995)
    “…Epithelial cancers in the lung and head and neck are a devastating group of diseases which account for approximately 35% of cancer deaths in the United States…”
    Get full text
    Journal Article
  5. 5

    A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors by Huber, M. H., Lee, J. S., Newman, R. A., Fossella, F. V., Wester, M., Hong, W. Ki, Lippman, S. M.

    Published in Annals of oncology (01-01-1996)
    “…Background Paclitaxel is a novel agent with significant activity in several solid tumors. Preclinical data suggested that methotrexate prior to pacitaxel would…”
    Get full text
    Journal Article
  6. 6

    4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-κB signaling pathways by Lee, Seung J., Seo, Kyo W., Yun, Mi R., Bae, Sun S., Lee, Won S., Hong, Ki W., Kim, Chi D.

    Published in Free radical biology & medicine (15-11-2008)
    “…4-Hydroxynonenal (HNE) accumulates at atherosclerotic lesions, but its role in the progression of atherosclerosis is not clear. Considering the role of matrix…”
    Get full text
    Journal Article
  7. 7

    The current status of docetaxel in solid tumors. An M. D. Anderson Cancer Center Review by Hong, W Ki

    Published in Oncology (Williston Park, N.Y.) (01-06-2002)
    “…In less than a decade, docetaxel (Taxotere) has progressed from initial studies in anthracycline-refractory metastatic breast cancer to several large, phase…”
    Get more information
    Journal Article
  8. 8

    Cilostazol: therapeutic potential against focal cerebral ischemic damage by Hong, Ki Whan, Lee, Jeong Hyun, Kima, Ki Young, Park, So Youn, Lee, Won Suk

    Published in Current pharmaceutical design (01-02-2006)
    “…Cilostazol was developed as a selective inhibitor of cyclic nucleotide phosphodiesterase 3 (PDE3). The anti-platelet and vasodilator properties of cilostazol…”
    Get more information
    Journal Article
  9. 9

    4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways by Lee, Seung J, Seo, Kyo W, Yun, Mi R, Bae, Sun S, Lee, Won S, Hong, Ki W, Kim, Chi D

    Published in Free radical biology & medicine (15-11-2008)
    “…4-Hydroxynonenal (HNE) accumulates at atherosclerotic lesions, but its role in the progression of atherosclerosis is not clear. Considering the role of matrix…”
    Get full text
    Journal Article
  10. 10

    4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-[kappa]B signaling pathways by Lee, Seung J, Seo, Kyo W, Yun, Mi R, Bae, Sun S, Lee, Won S, Hong, Ki W, Kim, Chi D

    Published in Free radical biology & medicine (01-11-2008)
    “…4-Hydroxynonenal (HNE) accumulates at atherosclerotic lesions, but its role in the progression of atherosclerosis is not clear. Considering the role of matrix…”
    Get full text
    Journal Article
  11. 11

    Distribution of HLA-A, -B and -DRB1 Alleles in Patients with Sudden Sensorineural Hearing Loss by YEO, Sang W, CHANG, Ki-Hong, SUH, Byung-Do, KIM, Tai-Gyu, HOON HAN

    Published in Acta oto-laryngologica (2000)
    “…This study was performed to investigate the association between human leukocyte antigen (HLA) and susceptibility to sudden sensorineural hearing loss in the…”
    Get full text
    Journal Article
  12. 12

    Chemosensitivity of murine renal carcinoma by de Vere White, R, Ki Hong, W, Tannenbaum, M, Olsson, C A

    Published in Urological research (01-02-1982)
    “…A non-endocrine dependent, spontaneous carcinoma of the kidney in a Wistar-Lewis rat has been studied for sensitivity to chemotherapeutic agents. Two tumour…”
    Get more information
    Journal Article
  13. 13

    Decomposition of Aggregate Energy and Gas Emission Intensities for Industry: A Refined Divisia Index Method by Ang, B. W., Choi, Ki-Hong

    Published in The Energy journal (Cambridge, Mass.) (01-07-1997)
    “…Several methods for decomposing energy consumption or energy-induced gas emissions in industry have been proposed by various analysts. Two commonly encountered…”
    Get full text
    Journal Article
  14. 14

    Hematologic effects of cis-platinum-bleomycin therapy by Najarian, T, Miller, A, Zimelman, A P, Ki Hong, W

    Published in Oncology (1981)
    “…A prospective study of the hematologic findings in 19 patients receiving cis-platinum (C-P) bleomycin (B) for squamous cell carcinoma of the head and neck was…”
    Get more information
    Journal Article
  15. 15